Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 6, 2008, Pages 1169-1176

  Zhou, Ji Yin ^a   Zhou, Shi Wen ^a   Zhang, Ke Bin ^a   Tang, Jian Lin ^a   Guang, Li Xia ^a   Ying, Yi ^a   Xu, Ying ^a   Zhang, Le ^a   Li, Dan Dan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Hyperglycemia; Hyperlipidemia; Liver; Peroxisome proliferator activated receptor; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BERBERINE; CHOLESTEROL; EOSIN; FENOFIBRATE; GLUCOSE; GLYCOGEN; HEMATOXYLIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPID DIET; LIPID METABOLISM; LIVER METABOLISM; LIVER WEIGHT; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; WEIGHT REDUCTION;

ANIMALS; BERBERINE; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIETARY CARBOHYDRATES; FATTY LIVER; GLYCOLIPIDS; HEMOGLOBIN A, GLYCOSYLATED; HEPATITIS, TOXIC; HYPERLIPIDEMIAS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER GLYCOGEN; MALE; ORGAN SIZE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RATS, WISTAR;

EID: 45749144363     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1169     Document Type: Article

References (37)

1. Peter P., Nuttall S. L., Kendall M. J., J. Clin. Pharm. Ther., 28, 167-174 (2003).
2. Taskinen M. R., Atheroscler. Suppl., 3, 47-51 (2002).
3. Berger J., Moller D. E., Annu. Rev. Med., 53, 409-435 (2002).
4. Schoonjans K., Staels B., Auwerx J., Biochim. Biophys. Acta, 1302, 93-109 (1996).
5. Schoonjans K., Staels B., Auwerx J., J. Lipid Res., 37, 907-925 (1996).
6. Wang Y. X., Lee C. H., Tiep S., Yu R. T., Ham J., Kang H., Evans R. M., Cell, 113, 159-170 (2003).
7. Luquet S., Gaudel C., Holst D., Lopez-Soriano J., Jehl-Pietri C., Fredenrich A., Grimaldi P. A., Biochim. Biophys. Acta, 1740, 313-317 (2005).
8. Inzucchi S. E., JAMA, 287, 360-372 (2002).
9. Li W., Dai R. J., Yu Y. H., Li L., Wu C. M., Luan W. W., Meng W. W., Zhang X. S., Deng Y. L., Biol. Pharm. Bull., 30, 1123-1129 (2007).
10. Liu J., Sun H., Duan W., Mu D., Zhang L., Biol. Pharm. Bull., 30, 2075-2078 (2007).
11. Li R. J., Qiu S. D., Chen H. X., Tian H., Wang H. X., Biol. Pharm. Bull., 30, 470-476 (2007).
12. Altern. Med. Rev., 5, 175-177 (2000).
13. Leng S. H., Lu F. E., Xu L. J., Acta Pharmacol. Sin., 25, 496-502 (2004).
14. Srinivasan K., Viswanad B., Asrat L., Kaul C. L., Ramarao P., Pharmacol. Res., 52, 313-320 (2005).
15. Oakes N. D., Thalen P. G., Jacinto S. M., Ljung B., Diabetes, 50, 1158-1165 (2001).
16. Khan M. A., St Peter J. V., Xue J. L., Diabetes Care, 25, 708-711 (2002).
17. Francis G. A., Annicotte J. S., Auwerx J., Am. J. Physiol. Heart Circ. Physiol., 285, H1-9 (2003).
18. Damci T., Tatliagac S., Osar Z., Ilkova H., Eur. J. Intern. Med., 14, 357-360 (2003).
19. Sharma S. B., Nasir A., Prabhu K. M., Murthy P. S., Dev G., J. Ethnopharmacol., 85, 201-206 (2003).
20. Arvind K., Pradeepa R., Deepa R., Mohan V., Indian J. Med. Res., 116, 163-176 (2002).
21. Elisaf M. S., Bairaktari H. T., Tziallas C. S., Germanos N. K., Siamopoulos K. C., Dial. Transplant., 24, 642-650 (1995).
22. Huang C., Zhang Y., Gong Z., Sheng X., Li Z., Zhang W., Qin Y., Biochem. Biophys. Res. Commun., 348, 571-578 (2006).
23. Dobrian A. D., Schriver S. D., Khraibi A. A., Prewitt R. L., Hypertension, 43, 48-56 (2004).
24. Pearson S. L., Cawthorne M. A., Clapham J. C., Dunmore S. J., Holmes S. D., Moore G. B., Smith S. A., Tadayyon M., Biochem. Biophys. Res. Commun., 229, 752-757 (1996).
25. Suwaki N., Masuyama H., Masumoto A., Takamoto N., Hiramatsu Y., Placenta, 28, 315-323 (2007).
26. Zhu Y., Alvares K., Huang Q., Rao M. S., Reddy J. K., J. Biol. Chem., 268, 26817-26820 (1993).
27. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., Jiang J. D., Nat. Med., 10, 1344-1351 (2004).
28. Brusq J. M., Ancellin N., Grondin P., Guillard R., Martin S., Saintillan Y., Issandou M., J. Lipid Res., 47, 1281-1288 (2006).
29. Herrman C. E., Sanders R. A., Klaunig J. E., Schwarz L. R., Watkins Iii J. B., Toxicol. Sci., 50, 146-151 (1999).
30. De Paepe M. E., Keymeulen B., Pipeleers D., Kloppel G., Hepatology, 21, 1144-1153 (1995).
31. Wang Z. J., Zhang Y., Li M. Q., Xu H. Y., Song Q. F., Wang Z. X., Pan J. H., Gan Zang, 10, 284-286 (2005).
32. Ameen C., Edvardsson U., Ljungberg A., Asp L., Akerblad P., Tuneld A., Olofsson S. O., Linden D., Oscarsson J., J. Biol. Chem., 280, 1224-1229 (2005).
33. Larsen P. J., Jensen P. B., Sorensen R. V., Larsen L. K., Vrang N., Wulff E. M., Wassermann K., Diabetes, 52, 2249-2259 (2003).
34. Janbaz K. H., Gilani A. H., Fitoterapia, 71, 25-33 (2000).
35. Zhao X., Zhang J. J., Wang X., Bu X. Y., Lou Y. Q., Zhang G. L., Biomed. Pharmacother. [Epub ahead of print], (2007).
36. Hwang J. M., Wang C. J., Chou F. P., Tseng T. H., Hsieh Y. S., Lin W. L., Chu C. Y., Arch. Toxicol., 76, 664-670 (2002).
37. Straczkowski M., Kowalska I., Gorski J., Kinalska I., Acta Diabetol., 37, 47-53 (2000).